Feedback / Questions
AZD4721 - Aristea, Pfizer
https://www.prnewswire.com/news-releases/aristea-therapeutics-announces-discontinuation-of-rist4721-development-program-and-decision-to-dissolve-the-company-301743732.html
Feb 10, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next